China Pharma Holdings, Inc. has announced its Annual Meeting of Stockholders will take place on December 22, 2026. This meeting is significant as it will cover essential topics such as the election of independent directors and a proposed reverse stock split of the company’s common stock. The filing indicates the company’s commitment to engaging its shareholders and addressing corporate governance issues.

The Annual Meeting will be held at the Conference Room, 2nd Floor, Jiahai Building, located at No. 17 Jinpan Road, Haikou, Hainan Province, China. The meeting is set to begin at 9:00 p.m. local time (8:00 a.m. Eastern Time). Stockholders of record as of November 2, 2026, will be eligible to vote on matters presented at the meeting.

Background

China Pharma Holdings, Inc. is a company primarily engaged in the pharmaceutical preparations industry, classified under SIC 2834. The company is listed on the NYSE under the ticker symbol CPHI. Recent filings include a preliminary proxy statement filed on October 30, 2026, and a quarterly report filed on August 14, 2026.

What the Filing Says

The preliminary proxy statement outlines the agenda for the upcoming Annual Meeting, which includes:

  • The election of three independent directors to serve until the next annual meeting.
  • Authorization of a reverse stock split of the company’s outstanding common stock at a ratio of up to 1:50.
  • Approval of an amendment to the Amended and Restated 2010 Long-Term Incentive Plan.
  • Discussion of any other business matters properly brought before the meeting.

The company emphasizes the importance of stockholder participation, encouraging them to vote via the Internet or by submitting a paper proxy card.

Impact

This meeting may significantly affect shareholders, as the proposed reverse stock split could impact the stock's market perception and liquidity. The election of independent directors is also crucial for enhancing corporate governance, which can lead to improved decision-making and strategic direction for the company.

What's Next

Following the Annual Meeting, stockholders will receive updates on the outcomes of the votes and any subsequent actions taken by the board. The filing does not specify further steps beyond the meeting.